Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05960474

Coronary Microvascular Disease (CMD) Registry

The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and externally for research purposes.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medstar Washington Hospital Center, Washington D.C., District of Columbia, United States

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those with Coronary Microvascular Disease

Treatment and study plan

Outcomes for Patients with CMD

Other

Our objective is to perform a retrospective/prospective descriptive study on the short term to longterm (up to 5 years of follow-up) outcomes of patients with coronary microvascular disease diagnosis invasively

Primary outcomes

  1. Establish a Registry of CMD patients

    Time frame: 10 years

Study contacts

Contact information is provided by the study sponsor or research team.

Kassandra Lopez

CONTACT

[email protected]

202-877-2452

Sponsors and collaborators

Lead sponsor

Medstar Health Research Institute

Other

Registry information

Important dates

Study start
2023
Primary completion
2033
Study completion
2033
First posted
Jul 25, 2023
Registry last updated
Jun 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.